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patient. The logical application of such observations,
based on the knowledge of the common patterns of
occlusive lesions associated with PAD and the limita-
tion in walking distance they commonly produce, can
lead to a presumptive clinical diagnosis." This can be
confirmed objectively as described in subsequent sec-
tions, by noninvasive testing in the form of segmental
limb pressures, plethysmography, and the occasional,
selective use of duplex scanning. This stepwise
approach allows proper management to be chosen in
most cases without the need for angiography.
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B 2.2
Investigation of Patients With Intermittent
Claudication
82.2.1
Routine Tests
The investigations discussed in this section should be
performed on all patients presenting to a physician for
the first time with Ie. In the absence of a recent abrupt
change in clinical status, any test that has already been
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performed in the previous months need not be repeat-
ed but should be noted. They are designed to detect
treatable risk factors or to diagnose associated dis-
eases, which have been discussed in an earlier section.
Basic haentatologic and biochemical studies
These should include a complete blood count (CBC;
includes red cell parameters, white cell count) and a
platelet count. The rationale for this is that, although
the haemoglobin or haematocrit will detect anaemia or
polycythaemia, either of which may precipitate or
aggravate the symptoms of claudication, a CBC will
also detect associated haematologic diseases (eg, chron-
ic myelogenous leukaemia) that may be unsuspected
yet influence treatment. The same can be said for an
abnormally high or low platelet count, but a baseline
platelet count is also useful for comparison, should the
patient be subsequently found to have a thrombocy-
topenia after treatment with heparin.
In addition, a fasting blood glucose level (FBG) or
haemoglobin Ale (HbAlc) and a creatinine level
should be obtained on all new, previously unstudied
patients. Diabetes is a significant risk factor in PAD and
may be occult for some time in type II diabetic patients.
Urinalysis for glycosuria/proteinuria also can be used
to detect diabetes. Similarly, azotaemia and raised
blood urea nitrogen (BUN) are insidious, and reduced
renal function is common in two of the major risk fac-
tors for PAD, diabetes and hypertension, whether of
renovascular origin or not. BUN and creatinine meas-
urements are also required before angiography or any
imaging studies requiring contrast media.
Blood lipid studies Patients with claudication have
systemic atherosclerosis and are at risk for fatal and
nonfatal MI and stroke. In PAD, the major lipid risk
factors for atherosclerosis are elevated low-density
lipoprotein (LDL) cholesterol and triglyceride levels
and low HDL cholesterol levels. Lp{a) is a lipoprotein
fraction that is an independent risk factor for PAD, but
there is no specific treatment for elevated Lp{a) levels
except to treat abnormalities in other lipid fractions
aggressively. Recent trials support the observation
that lipid modification can be associated with stabi-
lisation or regression of femoral atherosclerosis.v-'
Although lipid modification in patients with CAD is
associated with a reduction in the risk of vascular
death, similar trials have not been conducted in
patients with claudication, although it may be pre-
sumed that a similar benefit exists. It is recommended
that a screening lipid profile be obtained in all patients
with PAD. This consists of total cholesterol, HDL cho-
lesterol, and LDL cholesterol concentrations {the latter
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being calculated, not measured) as well as the triglyc-
eride concentration. This aspect is discussed in greater
detail later in thi s document (see B 4.1.2, Basic
Treatment, p S68).
Otherselected studies Although it cannot be justified
as a routine screening test, the erythrocyte sedimenta-
tion rate (ESR) is a simple and useful test in patients
with PAD. Although it is increased in a wide range of
acute and chronic inflammatory conditions, many of
these are vascular disorders, and a negative test rules
these out, whereas a positive test deserves further
study. For example, all typ es of hyperfibrinogenaemia
increase the ESR beyond the normal range, and there-
fore this is much simpler than measuring plasma fib-
rinogen itself in screening for hyperfibrinogenaemia.
An ESR also will detect hyperviscosity syndromes
caused by abnormal proteins such as myelomatosis.
Although a direct measurement of plasma viscosity is
more appropriate for detecting such conditions, this is
currently not widely available.
Some additional studies may be dictated by abnor-
malities in the initial routine tests, for example, plas-
ma fibrinogen, plasma viscosity, creatinine clearance,
or a bone marrow biopsy. Beyond this, the main rea-
son to obtain additional blood tests on a newly pre-
senting claudicant is a suspicion of a hypercoaguln-
ble state. Hypercoagulable state (or "thrombophilia")
is a term used to denote a number of clotting abnor-
malities leading to an increased tendency to throm-
bosis. These can be inherited or acquired. These are
listed in Table 13. The former include deficiencies in
protein C, protein S, and antithrombin and activated
protein C resistance or presence of factor V Leiden,
the latter now the most common hereditary risk
factor for DVT, being present in approximately 5% of
the white population.w
Originally, these clotting abnormalities were
thought to be associated only with abnormal venous
thrombosis and were seen at an early age,S as is gen-
erally true of homozygous states. There is now good
evidence that they also may be found, as heterozy-
gous states, in older patients with PAD. Importantly,
hypercoagulable states are frequent (up to 40%) in
patients undergoing revascularisation procedures
and even more frequent in those with failed vascular
intervention.s Finally, protein C deficiency can lead
to serious complications if coumarin is administered
without preliminary heparinisation." These findings
underscore the potential importance of screening
patients for hypercoagulable states.
In addition to inheritable clotting abnormalities,
there are a large number of acquired hypercoagulable
states (some of the better known of these are includ-
ed in Table 13). Antithrombin deficiency may be
acquired, most often in chronic debilitating diseases
in which there is poor nutrition and protein loss or
deficits. Hyperhomocysteinemia is more commonly
inherited but can be acquired, if the intake or absorp-
tion of folic acid is deficient. Both are more likely to
be encountered in those with severe leg ischaemia, in
which uncontrolled pain and poor nutrition go hand
in hand, than in patients with Ie.
Heparin-induced thrombooftopenia is more likely to
be encountered in those presenting with acute throm-
botic events and acute ischaemia but can develop in
any patient being treated with heparin or exposed to
heparin through indwelling catheters. However, in
patients presenting newly with claudication, only the
Table 13. Types of hereditary and acquired hypercoagulable states
Well-prol'ell hereditaryhypercol1gulabk stales
Factor V Leiden mutation (APC resistance)
Prote in C deficiency
Protein S deficiency
Antithrombin deficiency
Dysfibr inogcnacmia
Prothrombin mutation
Well-describedacquired hypercoagulable states
Antiphospholipid syndrome
Cancer-associated ("Trousseau's") thrombosis
Thrombosis associated with inflammatory bowel disea se
Antithrombin deficiency due to low-protein states (cg, protein-losing enteropathy, nephrotic syndrome, malnutrition)
Hypcrhomocysteinernia due to folic acid or vitam in 1312 def iciency (diet/absorption)
Presumed illheritable hypercoagulabh'states (controrersial/not yet sufficielltly ircl!characterised)
Plasminogen deficiency
Abnormal plasminogen
Plasminogen activa tor deficiency
Factor XII deficiency
Abnormal platelet reactivity
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Table 14. Typical tests used in identifying hypercoagulable states'
Primary Tests Additional Tests
Thrombin time Heparin-induced platelet antibodies
Prothrombin time
Activated partial thromboplastin time
Platelet count Platelet adhesiveness & aggregability
Platelet aggregation test for HITf
Plasma fibrinogen level
Plasminogen level
Euglobulin lysis time (screens for abnormalities in the fibrinolytic system)
Protein C assay/activity
Protein 5 assay/activity Crossed immunoelectrophoresis
Antithrombin assay/activity
Tests for antiphospholipid antibodies or lupus anticoagulant
Anticardiolipin antibody assay (lgG, IgM)
Dilute Russell Viper Venom Test
Resistance to activated protein C Assay for Factor V Leiden (screens for factor V Leiden)
Abbreviation: HITf, heparin-induced thrombosis and thrombocytopenia.
'These tests are used in variable combinations in stepwise screening.
presence of lupus anticoagulant, antiphospholipid anti-
bodies, myeloproliferative disorders, and certain malig-
nancies are likely to be of much clinical significance.
Although heparin-induced thrombocytopenia
produces a low platelet count and some cases of
lupus anticoagulant are detected by an elevated par-
tial thromboplastin time (PIT), the routine blood
clotting tests performed in most laboratories (eg, pro-
thrombin time [PTl, PTT, platelet count) do not effec-
tively detect the presence of a hypercoagulable state.
Although they should be obtained in patients con-
sidered for invasive interventions, they are not indi-
cated in all patients presenting with claudication.
However, a "hypercoagulable profile" should be
obtained in individuals with a personal or family his-
tory of thrombotic events, early age of onset «45
years), or the absence of any of the usual risk factors
for PAD, including a family history of atherosclerotic
complications. Similarly, patients with a low platelet
count and a history of exposure to heparin (as treat-
ment or in association with indwelling catheters)
who present with a new occlusive event should be
investigated for heparin-induced platelet antibodies.
Although serotonin release assays have been
employed, the classic test involves demonstration of
aggregation of normal (pooled) platelets by the
patient's own platelet-poor plasma in the presence of
heparin.
These confirmatory tests are expensive and should
be selectively employed." They usually consist of a
thrombin time, PT, PTT, plasma fibrinogen and plas-
minogen levels, a euglobulin lysis time, assays for
proteins C and 5 and antithrombin, an anticardi-
olipin antibody level, and a Dilute Russell Viper
Venom Test (DVVT) (to screen for antiphospholipid
antibodies). Activated protein C resistance is tested
Eur J Vase Endovasc Surg Vol 19 Supplement A, June 2000
using a modified method that gives meaningful
results in all clinical circumstances. This is a much
less expensive screen for factor V Leiden. If the
results of one or more of these tests are positive, an
additional tier of tests may be required to pinpoint
the diagnosis, such as crossed immunophoresis, C4B
binding protein, factor V Leiden assay, or the activi-
ties of tissue plasminogen activator or its inhibitor.
These are outlined in Table 14.
Finally, although the homozygous forms of homo-
cysteinuria and homocysteinemia have been recog-
nised for some time to be associated with premature-
onset PAD,IO increasing evidence links the heterozy-
gous state with increased risk of PAD. Elevated plas-
ma homocysteine levels are associated with a faster
rate of progression of PAD and are now considered
by many to be an independent risk factor for PAD.II
Therefore, plasma homocysteine levels should be
obtained on any patient presenting with claudication
who does not have any of the previously mentioned
usual risk factors associated with PAD.
Recommendation 13: Recommended laboratory
tests for new patients with intermittent claudica-
tion
The following blood tests should be performed in
all new patients presenting with intermittent clau-
dication:
• Complete blood count (haemoglobin, haernat-
ocrit, white cell count)
• Platelet count
• Fasting blood glucose or haemoglobin Alc
• Creatinine
• Fasting lipid profile
• Urinalysis (for glycosuria/proteinuria)
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Recommendation 14: Additional laboratory investi-
gations for atypical patients
The following laboratory investigations should be
performed selectively in atypical patients (eg, those
with early age of onset, atypical distribution of
occlusive lesions, personal or family history of
thrombotic events, lack of any of the common risk
factors for, or a family history of, atherosclerosis,
unexpected failed interventions):
• Hypercoagulability screen
• Homocysteine levels
Etaluaiion for atherosclerosis ill other regional
circulations
Further initial investigations are indicated, bearing in
mind that patients with IC are at particularly high risk
of atherosclerotic disease affecting other parts of the
circulation. PAD, due as it is to atherosclerosis, is
rarely an isolated disease process. Close to one third of
patients with PAD have clinically significant coronary
atherosclerosis.P and in those who are claudicants it is
often masked by exercise restrictions. Occult MI is not
uncommon, and a resting ECG should be routinely
obtained on all new patients with IC if no recent report
is available. This is essential in those patients consid-
ered for intervention, and in some of these, an addi-
tional diagnostic test for occult coronary disease such
as persantine thallium cardioscintigram or dobuta-
mine echocardiogram is indicated. An ECG on first
presentation wiII not only detect evidence of occult
infarct or unsuspected arrhythmias but serves as a
valuable baseline for future comparison.
Approximately one fourth of PAD patients have
hypertension, and in these consideration should be
given to the possibility of renal artery narrowing.
Finally, approximately 10% to 15% have cerebrovascu -
lar disease, mostly in the form of carotid stenosis.
Clearly, if a patient has a history, symptoms or signs,
or ECG evidence of cardiac disease, he or she will
need a referral to a cardiologist and further investiga-
tions (either noninvasive screening studies or, in some
instances, coronary angiography). Coronary disease
takes clear priority over claudication in the overall
management of the patient. The same applies to the
investigation and treatment of previously unsuspect-
ed hypertension, because better scre ening tests for
renovascular disease are now available.tv'! If a patient
describes symptoms of transient cerebral ischaemic
attacks or has a carotid bruit, a duplex scan of the
carotid bifurcation will detect any carotid artery steno-
sis or occlusion with reliable accuracy," There is ongo-
ing controversy about the value of screening all
patients with IC, symptomatic or not, for carotid di s-
ease and aortic aneurysms.te-?There is no doubt that
claudicant patients are more likely to have significant
asymptomatic disease in these areas than the general
population, but the treatment of asymptomatic carotid
disease is still controversial, and there is the issue of
yield versus cost of such screening tests.
Recommendation 15: Investigating other regional
circulations in peripheral arterial disease
A baseline resting electrocardiogram is recorn-
mended in new patients with intermittent claudica-
tion, but in the absence of family history, risk
factors, or suggestive symptoms or signs, there is as
yet no good evidence for routine further investiga-
tion of other circulations in such patients.
Patients with peripheral arterial disease have a high
associated prevalence of coronary, cerebrovascular,
and renal artery disease. Patients with symptoms or
signs suggesting atherosclerotic disease in other
regions will need further investigations and special
assessment.
Critical Issue 3: Screening for asymptomatic coro-
nary, carotid, and aortic aneurysmal disease in
patients with intermittent claudication
The cost-effectiveness of screening claudicants for
occult coronary artery, internal carotid, or aortic
aneurysmal disease needs to be evaluated.
Ankle pressure measurements
Measuring the pressure in the ankle arteries has
become a standard part of the"initial evaluation of
patients with PAD, including patients with Ie. A
sphygmomanometer cuff above the ankle with a
Doppler probe over the posterior tibial or dorsalis
pedis arteries is used to detect the return of flow after
cuff deflation, that is, the systolic pressure. Although
the absolute pressure correlates well with symptoms,
it is better standardised against the highest brachial
pressure, called the ankle.brachial pressure index
(ABPI), which serves as a baseline for comparing the
patient with himself/herself at different times. There
are several advantages to obtaining the ABPI on the
initial visit. First, it objectively confirms or rules out
the existence of haemodynamically significant occlu-
sive disease between the heart and the ankle, which in
almost all cases lies distal to the renal arteries. Second,
it provides a rough measure of the severity of the
occlusive disease for correlation with the patient's
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symptoms. Third, it can serve as an aid in differential
diagnosis, in that patients with exercise-related leg
pain of other causes will either have a normal ankle
pressure or a degree of reduction which does not fit
with the severity of disability. Finally, the ABPI can
detect lesser disease in the contralateral extremity,
which may not be suspected because it is masked by
the more severe symptomatic leg.
However, studies of the variability of ABPI meas-
urements between observers with varying degrees of
training and experience have shown that it should be
measured by experienced personnel." The variability
is partly related to the two pressure measurements
required for the index. The reproducibility of the ABPI
varies in the Iiterature.lt-" but it is significant enough
that reporting standards require a change of 0.15 in an
isolated measurement for it to be considered clinically
relevant, or greater than 0.10 if associated with a
change in clinical status." For the same reasons, even
though the ABPI is normally greater than 1.0 in nor-
mal patients, the cut-off point when screening for
occult PAD in large population-based studies is less
than 0.90 at rest. The comparison of the resting ABPI
with that recorded after a degree of exercise that pro-
duces pain provides useful information and is
described in the next section.
Recommendation 16: Ankle:Brachial Pressure
Index in intermittent claudication
The ankle:brachial pressure index (ABPI) should
be measured in both legs in all new patients with
intermittent claudication.
82.2.2
Special Investigations Other Than Imaging
The primary justification for special investigations in
the claudicant is where they contribute significantly
to accuracy of diagnosis, or supply needed informa-
tion that affects the further management of the
patient. This is particularly the case if it helps deter-
mine the need for and feasibility of, different forms
of interventional therapy. In many instances, the sim-
pler noninvasive tests, such as segmental limb pres-
sure determinations, may be justified on the grounds
that they more accurately characterise the location
and severity of the occlusive lesions.
In contrast, the more invasive and expensive of
these tests, angiography, is not routinely used in
patients with IC, whereas it is frequently applied to
those with CU, in which the consideration of limb
loss and intervention to prevent it apply in almost
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every case. Most of the investigations described in
later sections are intended to characterise the under-
lying anatomic lesions or the haemodynamic
changes they produce. They basically consist of
either physiological testing or vascular imaging, the
latter using noninvasive or invasive methods (eg,
duplex scanning or contrast angiography). It should
be noted that common practice in relation to nonin-
vasive investigations used in patients differs widely
between Europe and North America. For example,
segmental limb pressures (SLP), pulse volume
recordings (PVR), and velocity waveform analysis
(VWF) are much more widely used in North
America, where there is already considerable experi-
ence in their use and interpretation. In Europe, how-
ever, a preferred alternative to these tests is duplex
scanning.
Segmental limbsystolic pressure measurement (SLP)
SLP is now widely used because it accurately detects
and segmentally localises haemodynamically signifi-
cant large-vessel occlusive lesions in the major arteries
between the heart and the measuring point. One such
pressure measurement, the ankle pressure, is so rou-
tine that it has been already discussed under basic
investigations. Segmental measurements at other lev-
els down the leg (upper and lower thigh and calf), in
addition to the ankle, are obtained in the same fashion
as the ankle pressure (AP). A sphygmomanometer cuff
is placed at a given level with a Doppler probe over
one of the pedal arteries, and the systolic pressure in
the major arteries under the cuff is measured. The
location of occlusive lesions is apparent from the pres-
sure gradients between the different cuffs.P
Although some prefer a single large, wide thigh cuff
because of its low false-positive rate, such a cuff strad-
dles the femoral bifurcation and therefore does not
distinguish well between proximal (iliac) and distal
(femoropopliteal) disease, which upper and lower
thigh cuffs of regular width do more accurately.P The
latter cuffs, however, give an artifactual high upper
thigh pressure, by 25% or more, because of the girth of
the upper thigh relative to the cuff's width, but this is
worth adjusting for, in exchange for a better separa-
tion of proximal and distal disease. The accuracy of
this test alone in detecting and localising occlusive
lesions has been reported to be 85%, blinded against
anglography> The main problems are (1) missing iso-
lated moderate stenoses (usually iliac) that produce
little or no pressure gradient at rest and (2) falsely ele-
vated pressures in diabetic patients with calcified,
incompressible arteries."
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Special considerations in etaluaiing diabetic patients
Patients with long-standing diabetes commonly
develop calcified, incompressible vessels, which cause
false high SLP measurements, particularly at the ankle
level. The presence of this artifact is obvious when the
measured SLP are all unbelievably high (eg, 300 mm
Hg) or ABPI is greater than 1.5,but subtler degrees can
be misleading. The usual clue is that the SLP readings
are much higher than brachial pressure and increase
from thigh to ankle rather than gradually decrease, as
they normally do. This is because the more distal
(crural) arteries are usually more severely involved,
and at times only the AP is falsely elevated. Although
the frequency of false pressure measurements in dia-
betic patients has probably been exaggerated in the
past, it remains a significant problem.> A partial solu-
tion, a substitute for a falsely elevated AP, is to meas-
ure the toe pressure. A special small occlusion cuff is
used proximally on the first or second toe with some
flow sensor, such as digital plethysmography using a
light-emitting diode, beyond itP This is feasible
because, even in long-standing diabetes, the more dis-
tal pedal vessels are usually not calcified and therefore
compressible.
The toe pressure is normally approximately 10 mm
Hg less than the ankle pressure. But, like ankle pres-
sures, measuring toe pressures as an isolated test is
more useful in assessing patients with eLI than those
with claudication. For that reason, it is described in
more detail later, in the appropriate section.
Furthermore, measuring toe pressures does not help
localise occlusive lesions proximal to that point. That
is, it can substitute an ankle pressure but does not
solve the problem of falsely elevated SLP measure-
ments proximal to that point. This can be overcome by
segmental plethysmography or pulse volume record-
ings (PVRs; see next section), and this approach is
helpful even if segmental limb pressures can be accu-
rately measured.
Segmentalplethysmography or pulse uolutne recordings
(PVR)
A plethysmograph is any instrument that detects and
graphically records volume change. To perform seg-
mental plethysmography, any instrument that meas-
ures the relative change in volume associated with
each cardiac cycle in the segment of limb encircled by
a plethysmographic sensor may be used. Although
mercury-in-silastic tube strain gauges or impedance
strips encircling the limb at selected levels can be
used, in common practice calibrated air-filled cuffs,
much like sphygmomanometer cuffs, are employed.
They are placed around the leg at selected locations
and connected to a plethysmograph, which produces
a "pulse volume recording" (PVR).28 Normally a sin-
gle large thigh cuff is used along with regular-sized
calf and ankle cuffs, plus a brachial cuff, which reflects
the undampened cardiac contribution to arterial pul-
satility. The latter is useful in standardising the lower-
limb PVR and in detecting poor cardiac function as a
cause of -low-amplitude tracings. By comparing the
magnitude and contour of each PVR with that record-
ed at the proximal or distal cuff, whether there is a sig-
nificant occlusive lesion between them can be deter-
mined.
In the study cited above, both SLP and PVR meas-
urements alone were 85% accurate compared with
angiography in detecting and localising significant
occlusive lesions.s- Furthermore, when used together
in a complementary fashion, they were over 95%
accurate. For this reason, these two diagnostic meth-
ods are often used together when evaluating PAD. By
using them in combination, diabetic patients with
calcified arteries sufficient to produce falsely elevat-
ed SLP will be readily recognised and correctly
assessed by PVR.
Doppler Velocity Wave Form (VWF) analysis
This is used in some Vascular Diagnostic
Laboratories, instead of PVR, to complement SLP.
Here, arterial VWF is recorded using a continuous-
wave Doppler over the femoral, popliteal, posterior
tibial, and dorsalis pedis arteries. Similar to the inter-
pretation of PVR, qualitative differences in the mag-
nitude and contour of VWF between two adjacent
recording points identifies the presence of an occlu-
sive lesion in the intervening arterial segment.s? This
may even be quantified for greater accuracy.v
However, VWF recording and analysis is very opera-
tor dependent, and for that reason PVR are preferred
by most. VWF analysis is not widely used in Europe.
These tests are painless, quick, inexpensive, and
accurate enough in detecting and localising arterial
occlusive disease in most. cases, that vascular imag-
ing is only occasionally necessary in patients with l'C,
Their major weakness is that they are based on indi-
rect information and can identify a haernodynamic
occlusive lesion in a particular arterial segment but
cannot further characterise it . For example, they can-
not distinguish between a tight localisedstenosisand a
wcll-collateralised long occlusion, Because this may
well affect the decision to intervene (with PTA),
duplex scanning is called for in these circumstances.
Duplex scanning is admittedly more accurate than
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SLP alone. In a study by Moneta et a1,31 duplex was
97% accurate (vs 75% for SLP alone) in detecting
superficial femoral artery lesions with >50% luminal
narrowing and 91% accurate (vs 54% for SLP alone)
in detecting similar lesions in the popliteal artery.
It is noteworthy that this comparison was not per-
formed at the iliac and tibial artery levels, where
duplex is much less accurate. Furthermore, the
demonstrated advantage is mainly with lesser
degrees of stenosis, of questionable clinical signifi-
cance, and would not be as great if SLP had been
combined with PVR. Finally, duplex scanning, partic-
ularly a complete study of both lower-extremity
arteries, is very time consuming and relatively much
more expensive than SLP and PVR. The recommend-
ed. applications of duplex scanning are discussed
later.
Recommendation 17: Noninvasive localisation of
lesions
If it is desirable to localise and gauge the severity of
occlusive arterial lesions to assist in planning an
intervention; then duplex scanning or magnetic res-
onance angiography (depending on local availabil-
ity, experience, and cost) can be used as a prelimi-
nary, noninvasive examination before angiography.
In many cases, the information supplied by simpler
tests such as segmental limb pressure or pulse
volume recording is adequate for decision making.
Functional testing, using treadmill exercise or other ntetnts
of inducing limb hyperaemia
At rest, the lower-extremity arterial circulation is the
prototype low-flow, high-resistance circulation.
Exercise reverses this, and the high-flow, low-resistance
haemodynamics that result either magnify resting pres-
sure gradients associated with occlusive arterial lesions
or produce them where undetectable by resting studies.
Measuring the pressure gradients, typically the change
in the ABPI associated with a standardised exercise pro-
tocol, or those produced by other forms of induced
hyperaemia, is the best accepted method for quantify-
ing function and disability in patients with Ie.
Although these pressure gradients can be measured
between monitoring cuffs at any level, just as with rest-
ing SLP, for practical reasons only brachial and ankle
cuffs arc routinely used.
The usual treadmill exercise test to assess the
haemodynamic significance of arterial occlusive
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disease in the lower extremities is performed in a vas-
cular diagnostic laboratory. The patient walks at a
standard speed and grade on a treadmill until claudi-
cation pain is experienced or a time limit has been
reached, for example.f minutes at 3.5 km/h on a 12%
incline. The latter is equivalent to walking nearly 600
metres at average speed. With a significant arterial
occlusive lesion, there will be a sign ifican t decrease in
the ABPI from resting to the postexercise level, nor-
mally measured 1 minute after exercise. Even in
patients with known pulse deficits, other conditions
(eg, arthritis) can be the cause of the discomfort expe-
rienced with exercise; therefore, it is important to note
the degree of drop in ABPI in this test.
If ischaemia is causing the pain that terminates the
test, the post-exercise ankle pressure should be con-
side rably lower than the resting value, often in the
range of 50 mm Hg. In severe cases, the ABPI may be
unrecordable for several minutes. This "treadmill test"
is not to be confused with that used in screening for
coronary disease, in which the patient is pushed well
beyond the limits of usual walking. Similarly, it
should not be confused with the treadmill protocols
used in gauging walking distance during clinical trials
of the efficacy of pharmacotherapy and other treat-
ments. These have been mentioned earlier in Outcome
Assessment Methodology (A3, p S30) and is
described again in detail later in Clinical Trial Issues
(B6, p 5108).
Altemativc stress tests
Some elderly or otherwise disabled patients cannot
perform treadmill exercise, and treadmills are not uni-
versally available, so alternative methods of simulat-
ing these haernodynamics have been tried. To over-
come the unavailability of a treadmill, some centres
have timed patients walking in adjacent corridors
until claudication develops, and then they record the
ankle pressure. Unfortunately, even when the patient
is accompanied by a technician , walking speed is quite
variable.
A second alternative is to inflate a thigh cuff well
above systolic pressure for 3 to 5 minutes, producing a
similar degree of "reactive" hyperaemia." The
decrease in AP 30 seconds after cuff deflation is rough-
ly equivalent to that observed 1 minute after walking
to the point of claudication on a treadrnill.P
Unfortunately, many patients do not tolerate the dis-
comfort associated with this degree and duration of
cuff inflation. Dorsiflexion of the foot with the leg ele-
vated 30° also has been used, but it does not produce
nearly the same degree of pressure drop.
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B 2.2.3
Imaging Techniques
IIIdicatioII5 for imagillg ill patients toith intermittent clau-
dicaiion
Imaging is indicated if some form of intervention
would be advised if a suitable lesion is demonstrat-
ed . This is covered in detail later in Overall Strategy
(p S66), but it deserves brief comment here for
emphasis. The decision regarding the appropriate-
ness of intervention is arrived at by balancing the
patient's disability against the immediate risks and
long-term benefits of a particular intervention com-
pared with other alternatives, such as regular exer-
cise training or pharmacotherapy. The patient's dis-
ability can and should be assessed at the initial visit.
This is considered in terms of not only claudication
distance but how this limitation affects the patient's
lifestyle, as well as independence and self-care-in
other words, everyday living requirements and pref-
erences.
The detailed risks and results of catheter proce-
dures and vascular reconstruction are considered in
Endovascular Procedures (p 582), but clearly the
risks of PTA are considerably less than the risks of a
surgical reconstruction. Therefore, the indications for
intervention, and thus imaging as well, have signifi-
cantly increased in the last 10 to 15 years. Similarly,
the expense and morbidity rate for duplex scanning
are far less than for angiography, and with the intro-
duction of colour coding and other technological
advances, it is now possible to use Duplex scanning
in many situations to assess the suitability of the
underlying lesions for the proposed intervention
before committing to angiography.
The clinical examination of the patient may give
some indication as to whether a suitable lesion for
percutaneous intervention is likely to be found. For
example, if a patient has full, easily palpable pulses
at the level of the popliteal, it is most unlikely that
imaging will show a lesion that can be easily and
safely treated by percutaneous techniques, that is, the
disease is in the crural vessels. By contrast, if a
patient has a diminished femoral pulse and a proxi-
mal bruit, the disease is most likely to be a narrowing
of the iliac arteries. In this case, some form of catheter
procedure may be feasible and appropriate. The
same may be said for noninvasive physiological test-
ing. However, such tests primarily localise occlusive
lesions and assess their relative hacmodynamic sig-
nificance without distinguishing between a tight
stenosis and a complete occlusion. Here duplex scan-
ning may add valuable information, distinguishing,
for example, between a short distal SFA stenosis and
a long complete occlusion. The former is suitable for
PTA; the other requires bypass. Thus, proper appli-
cation of imaging techniques provides the firmest
foundation for the decision to intervene.
Choice of imaging methods
The main reason to image the arteries supplying the
c1audicating leg is to find and define an arterial lesion
that has a suitable morphology for some form of inter-
vention, radiological or surgical. The current options
are angiography, duplex scanning, or some form of
magnetic resonance imaging (MRI/MRA).
Allgiography Angiography carries a certain morbid-
ity risk (approximately 0.1% risk of severe reaction to
contrast rnedium.>' 0.7% complications risk severe
enough to alter patient management, and 0.16% mor-
tality risk35) and significant additional expense, as well
as being an unpleasant experience for many patients.
Other studies quote lower mortality rates (see B 4.1.1,
Ov erall Strategy, p 566). These problems have been
greatly mitigated by technological improvements such
as nonionic contrast agents, digital subtraction
angiography, intraarterial pressure measurements
across a stenosis with and without vasodilators." and
more sophisticated image projection and retention,
etc. Alternatively, carbon dioxide can be used instead
of conventional contrast media. In high-risk (eg, renal
impairment) and other selected patients, restriction to
a partial study with selected views rather than visual-
ising the entire infrarenal arterial tree has decreased
the contrast load, length of study, and associated
risks.37•3s Nevertheless, full angiography, with visuali-
sation from the infrarenal aorta to the pedal arteries
using digital subraction angiography (D5A) tech-
niques, remains the choice in most cases.
Recommendation 18: Indications for angiography
in intermittent claudication
Angiography in a patient with intermittent claudi-
cation is usually indicated only when a decision
has been made to intervene, should a suitable
lesion be identified.
Colour duplex imagillg Colour duplex imaging has
been proposed as an attractive alternative to angiogra-
phy in that it does not share 'many of its disadvan-
tages. In addition to being completely safe and much
less expensive, duplex scanning, in expert hands, can
provide most of the essential anatomic information
plus some functional information-for instance, veloc-
ity gradients across stenoses. The lower extremities'
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arterial tree can be visualised, with the extent and
degree of occlusive lesions accurately assessed and
arterial velocities measured. The disadvantages of
colour duplex scanning are that there are too few suf-
ficiently trained personnel for it to be widely avail-
able; obtaining information similar to angiography is
dependent on the duplex operator. Furthermore, there
is no hard copy equivalent to an arteriogram.
Although multiple Polaroid images or videotapes can
be made, they are not useful in actual practice. The lat-
ter, plus the extra security of being able to view the
entire arterial tree in fine detail, means that most vas-
cular surgeons require angiography before undertak-
ing a vascular reconstruction.
This is not the case if percutaneous revascularisation
(eg, balloon angioplasty or atherectomy) is to be under-
taken, because such procedures inevitably involve con-
comitant arteriographic imaging of the relevant vessels.
Thus, duplex scanning can serve as a screening test for
many catheter-based interventions. However, because
SLP and PVR are quicker and cheaper, and supply
much of the information required for decision making,
even when PTA is contemplated, there is little justifica-
tion for duplex scanning of the entire extremity arterial
tree, particularly in patients with Ie. In this setting,
duplex scanning is usually applied selectively, in the
same vascular laboratory and at the same time as SLP
and PVR, interrogating just those segments where addi-
tional information is needed, usually searching for dis-
crete lesions amenable to percutaneous revascularisa-
tion techniques.
To summarise, if a patient qualifies for invasive
therapy, angiography will ultimately be required in
almost .all elective cases, preoperatively for surgical
reconstruction, and before or during catheter-based
interventions. Duplex scanning is used selectively
mainly to characterise specific lesions in regard to
their suitability for endovascular treatment. However,
it should be kept in mind that arterial reconstructive
surgery can be performed on the basis of duplex scan-
ning alone in some cases.39AOThis not only has value
for those who are allergic to contrast media, but it
offers potentially significant cost savings. Therefore,
improved technology, wider training of surgeons as
well as technicians, and cost considerations should
increasingly promote this approach in the future.
Magnetic Resonance Allgiography (MRA) The other
possible future scenario is that MRA may become the
preferred imaging technique, as a practical compro-
mise between duplex imaging and angiography,
although with current techniques it tends not to dis-
tinguish well between tight stenoses and complete
occlusions. However, for at least aortoiliac disease,
some studies have shown that the best MRA tech-
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niques are adequate for stenosis qualification and dis-
criminating between stenosis and occlusion.41A2A3 In
some cases MRA (especially with contrast enhance-
ment) may be as good as conventional angiogra-
phy.44.45.46.47.4S Further studies are needed to determine
to what extent MRA may replace angiography.
Spiral Computed Tomography (CT) Spiral CT is also
being used for the noninvasive evaluation of proxi-
mal, that is, aortoiliac occlusive, disease.
Critical Issue 4: Alternative investigations to
angiography
Further studies are needed to determine to what
extent duplex scanning, magnetic resonance
angiography, or other new imaging modalities may
replace angiography for many applications in the
future.
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OUTCOME ASSESSMENT OF INTERMITTENT
CLAUDICATION IN CLINICAL PRACTICE (SEE
ALSO A 2.2, INTERMITTENT CLAUDICATION,
P S4)
A detailed assessment of outcomes necessary for clini-
cal trials or published studies is discussed in B6,
Clinical Trial Issues (p 5108). IC is an indicator of not
only blood flow-limiting lesions within the arterial
tree of the lower extremity but also clinically signifi-
cant systemic atherosclerosis. As such, IC exerts a
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